Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Lee Jackson | Dec 11, 2017 at 9:50 AM EST

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for…

Chris Lange | Dec 8, 2017 at 12:00 PM EST

Denali Therapeutics Enters the Market With a Bang

Denali Therapeutics entered the markets with a bang on Friday. In its initial public offering, the company priced its almost…

Chris Lange | Dec 8, 2017 at 11:10 AM EST

Radius Health Breast Cancer Trial Continues to Show Progress

Radius Health shares climbed higher on Friday after the firm provided an update on its early-stage clinical study in patients…

Paul Ausick | Dec 8, 2017 at 11:00 AM EST

Americans Favor Government-Mandated Health Care Again: Gallup

More than half of Americans now believe that government has a responsibility to make sure that all Americans have health…

Chris Lange | Dec 8, 2017 at 10:40 AM EST

Is This the Turnaround SteadyMed Has Waited For?

SteadyMed saw its shares make an incredibly gain to close out the week, after a positive meeting with the FDA.

Chris Lange | Dec 8, 2017 at 9:40 AM EST

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals shares saw a handy gain early on Friday after the New York Times reported that there might be…

Chris Lange | Dec 7, 2017 at 12:20 PM EST

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Sage Therapeutics saw its shares make an incredible gain on Thursday after the firm announced positive top-line results from its…

Chris Lange | Dec 6, 2017 at 11:40 AM EST

Arrowhead Pharma Wins in Midstage Hepatitis Study

Arrowhead Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm presented new data from its midstage…

Jon C. Ogg | Dec 6, 2017 at 11:10 AM EST

How a Key Health Care Merger May Play a Role in Warren Buffett’s Investing

DaVita has long been considered a takeover target, with a twist involving Warren Buffett. How will analysts value DaVita in…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Chris Lange | Dec 5, 2017 at 11:40 AM EST

Quanterix Gears Up for IPO

Life sciences company Quanterix intends to price more than 3 million shares in a range that results in an initial…

Chris Lange | Dec 5, 2017 at 10:15 AM EST

Revance Scores Solid Results in Late-Stage Trial

Shares of Revance Therapeutics saw a solid gain early on Tuesday after the company announced positive top-line results from its…

Lee Jackson | Dec 4, 2017 at 8:10 AM EST

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

These four momentum biotech plays still have solid upside to the Jefferies price targets and would be solid additions to…

Chris Lange | Nov 30, 2017 at 10:50 AM EST

Why Apple Is Propping Up BioTelemetry

BioTelemetry saw its shares make a handy gain on Thursday after a new partnership with Apple to provide cardiac monitoring…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

1 … 148 149 150 151 152 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

Denali Therapeutics Enters the Market With a Bang

Radius Health Breast Cancer Trial Continues to Show Progress

Americans Favor Government-Mandated Health Care Again: Gallup

Is This the Turnaround SteadyMed Has Waited For?

Will Alexion Pharmaceuticals Fight This Activist?

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Arrowhead Pharma Wins in Midstage Hepatitis Study

How a Key Health Care Merger May Play a Role in Warren Buffett’s Investing

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Quanterix Gears Up for IPO

Revance Scores Solid Results in Late-Stage Trial

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

Why Apple Is Propping Up BioTelemetry

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

Health and Healthcare Articles

All Health and Healthcare Articles

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

Denali Therapeutics Enters the Market With a Bang

Radius Health Breast Cancer Trial Continues to Show Progress

Americans Favor Government-Mandated Health Care Again: Gallup

Is This the Turnaround SteadyMed Has Waited For?

Will Alexion Pharmaceuticals Fight This Activist?

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Arrowhead Pharma Wins in Midstage Hepatitis Study

How a Key Health Care Merger May Play a Role in Warren Buffett’s Investing

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Quanterix Gears Up for IPO

Revance Scores Solid Results in Late-Stage Trial

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

Why Apple Is Propping Up BioTelemetry

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

U.S. Navy intercepts Iranian cruise missiles — 4 defense stocks to watch today

AMZW’s Weekly Payouts Drop 79% as Volatility Collapses; Can Investors Count on Them?

The Reverse Mortgage Line of Credit That Grows Untouched for 15 Years and Becomes a $700,000 Liquidity Buffer at 80

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how